Clinical profiling of BCL-2 family members in the setting of BRAF inhibition offers a rationale for targeting de novo resistance using BH3 mimetics (Q33830911)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical profiling of BCL-2 family members in the setting of BRAF inhibition offers a rationale for targeting de novo resistance using BH3 mimetics |
scientific article |
Statements
1 reference
Clinical profiling of BCL-2 family members in the setting of BRAF inhibition offers a rationale for targeting de novo resistance using BH3 mimetics (English)
1 reference
Keith T Flaherty
1 reference
David E Fisher
1 reference
Jennifer A Wargo
1 reference
Roberto A Salas Fragomeni
1 reference
Dennie T Frederick
1 reference
Aislyn Schalck
1 reference
Isabel Ferreiro-Neira
1 reference
Taylor Hoff
1 reference
Rizwan Haq
1 reference
David J Panka
1 reference
Lawrence N Kwong
1 reference
Michael A Davies
1 reference
James C Cusack
1 reference
James W Mier
1 reference
Ryan J Sullivan
1 reference
1 July 2014
1 reference
1 reference
e101286
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference